Guest edited by Drs. Marjorie Eskay-Auerbach and Robert Rondinelli, this issue of Physical Medicine and Rehabilitation Clinics will discuss Medical Impairment and Disability Evaluation and Associated Medicolegal Issues. This issue is one of four selected each year by our series Consulting Editor, Dr. Santos Martinez of the Campbell Clinic. Topics in this issue include, but are not limited to: The Physician's Approach to Impairment Rating and Disability Benefits Determinations; Claimant-related Issues; Evaluating Return-to-work ability using Functional Capacity Evaluation; Evaluating Human Functioning Using CAT Methodology for Disability Determination within the SSA; Burden of treatment compliance; Measuring Quality of Life Loss in Litigation; Medical-Legal Causation Analysis; Actuarial Analysis and Life Expectancy Determination after Catastrophic Illness or Injury; Validity Assessment in Acquired Brain Injury Disability Evaluation; Medicolegal Expert Core Competencies & Professionalism; The Physician as Expert Witness; Rehabilitating the Injured Worker to Maximum Medical Improvement (MMI); The Independent Medical Examination (IME); and Life Care Planning, among other topics.

This issue of Physical Medicine and Rehabiltiation Clinics, guest edited by Drs. Karen Barr and Ileana Michelle Howard, will cover several key aspects of Value-Added Electrodiagnostics. At the invitation of series Consulting Editor Dr. Santos Martinez, the editors put together a comprehensive issue discussing topics including: Targeting interventions for fall risk reduction; Detecting toxic myopathies as medication side effect; Predicting response from interventional spine procedures; Planning interventions to treat plexopathies; Minimizing risk of cancer therapeutics; Predicting Recovery from Peripheral Nerve Trauma; Detecting complications of metabolic syndrome and diabetes; Steering peripheral neuropathy work-up; Elucidating the cause of pelvic pain; and Guiding treatment for foot pain, among others.

While some individuals with asthma consider the condition only a minor nuisance, for others it significantly interferes with daily activities and may even be life-threatening. This book offers readers a broad introduction to this common respiratory issue. Asthma is a respiratory condition marked by spasms, swelling, and excess mucus production in the bronchial passages of the lungs. This triggers coughing, wheezing, chest tightness, and shortness of breath. While asthma can usually be managed with medications and avoidance of certain triggers, it's a serious-potentially deadly-chronic disease. What You Need to Know about Asthma is part of Greenwood's Inside Diseases and Disorders series. This series profiles a variety of physical and psychological conditions, distilling and consolidating vast collections of scientific knowledge into concise, readable volumes. A list of "top 10" essential questions begins each book, providing quick-access answers to readers' most pressing concerns. The text follows a standardized, easy-to-navigate structure, with each chapter exploring a particular facet of the topic. In addition to covering such basics as causes, signs and symptoms, diagnosis, and treatment options, books in this series delve into issues that are less commonly addressed but still critically important, such as effects on loved ones and caregivers. Case illustrations highlight key themes discussed in the book and are accompanied by insightful analyses and recommendations. Approaches the subject in a holistic manner, covering such often-overlooked areas as societal perceptions and impact on family and friends An Essential Questions section provides quick answers to the questions readers are most likely to have and serves as a springboard to explore the content of the book in more detail Case Illustrations provide relatable, real-world examples of concepts discussed in the text An annotated Directory of Resources points readers toward useful books, organizations, and websites, acting as a gateway to further study and research

An overview written for general readers of the history, prevention, treatment, causes, and consequences of obesity. What makes obesity a disease instead of just a matter of overeating? What are the genetic and environmental factors behind it? What new breakthroughs are being developing to combat it? This concise, information-rich volume looks at these and other important questions, clearing away misconceptions about this devastating condition. Obesity explains what scientists now know about the causes and consequences of being overweight, including the latest on the links between obesity and heart disease, diabetes, some cancers, asthma, and sleep difficulties. The book pays specific attention to the problem among obese young people, who more and more are being diagnosed with chronic illnesses that used to only be seen in adults. It also reports on promising efforts to battle obesity, from medical treatments to community awareness programs. The work is combines materials from history, epidemiology, behavioral science, surgery, pharmacology, economics, and policy Includes a glossary of key terms related to the study of obesity

Learn not only how to recognize high-quality research, but how to improve your own research and apply it to patient care. Plus, find out how to start a journal club, write quality case reports and how to most effectively present your research to others. This book is ideal guide for students at both graduate and undergraduate levels who might be having difficulty with research concepts as well as for practiced clinicians interested in a fresh approach to clinical research. * A jargon-free guide to understanding and conducting research * Uses metaphors, visual images, and examples to simplify complex research concepts * Includes easy-to-do computer exercises to help you understand statistical concepts

Obesity: Oxidative Stress and Dietary Antioxidants cover the science of oxidative stress in obesity and associated conditions, including metabolic syndrome, bariatric surgery, and the potentially therapeutic usage of natural antioxidants in the diet or food matrix. The processes within the science of oxidative stress are not described in isolation, but in concert with other processes, such as apoptosis, cell signaling and receptor mediated responses. This approach recognizes that diseases are often multifactorial and oxidative stress is but a single component. The book is designed for nutritionists, dietitians, food scientists, physicians and clinical workers, health care workers and research scientists.

Neurobiology of the Placebo Effect, Part I, Volume 138 in the International Review of Neurobiology series, is the first of two volumes that provide the latest placebo studies in clinically relevant models. Placebo responses effects are not merely a psychological, but a complex psycho-neuro-biological process that requires activation of distinct brain areas. This book discusses current research and projects on the involved brain circuitry and neurotransmitter systems. Specific chapters cover such topics as pharmacological conditioning of the endocrine and immune system, expectancy modulation of opioid neurotransmission, nocebo effects in visceral pain, and conditioning as a higher-order cognitive phenomenon, amongst other topics.

Nanostructures for Novel Therapy: Synthesis, Characterization and Applications focuses on the fabrication and characterization of therapeutic nanostructures, in particular, synthesis, design, and in vitro and in vivo therapeutic evaluation. The chapters provide a cogent overview of recent therapeutic applications of nanostructured materials that includes applications of nanostructured materials for wound healing in plastic surgery and stem cell therapy. The book explores the promise for more effective therapy through the use of nanostructured materials, while also assessing the challenges their use might pose from both an economic and medicinal point of view. This innovative look at how nanostructured materials are used in therapeutics will be of great benefit to researchers, providing a greater understanding of the different ways nanomaterials could improve medical treatment, along with a discussion of the obstacles that need to be overcome in order to guarantee widespread availability.

Years of experience, level of qualification, modality delivered, supervision, personal therapy, and continuing professional development are not predictive of client outcomes in psychotherapy. Further, the outcomes of psychotherapy have not improved in over 40 years, despite the proliferation of new therapy modalities. Evidence Based Counselling & Psychotherapy for the 21st Century Practitioner answers how counselling and psychotherapy can be operationalised in the 21st century, dispelling long-held beliefs about how psychotherapy works. Discussing evidence-based practice in its various forms, the chapters provide an analysis of research used and the debate around the effectiveness of specific therapies, commonalities across therapies and the many evidence-based relationship variables that are said to contribute to effective psychotherapy. Client factors and the use of technology, deliberate practice, supervision, and a simulated client case demonstrate the application of the methods and ideas reviewed. Whether a novice psychotherapy trainee or a seasoned practitioner or supervisor, Evidence Based Counselling & Psychotherapy for the 21st Century Practitioner illustrates what an effective 21st century practitioner needs to know, do, and reflect on to improve the effectiveness of their psychotherapeutic work and client outcomes - of interest across the allied health and social care sectors where counselling and therapy interventions are used.

The volume will serve as a primer on tyrosine kinase signaling and its importance in cancer. The volume will first introduce the common denominators of small-molecule and antibody-derived inhibitors, as well as the general phenomenon of resistance. The volume will then detail resistance to the most commonly used classes of tyrosine kinase inhibitors, and will focus specific chapters on resistance to BCR-ABL1, FLT3, angiokinase family members, and ALK inhibitors.

Almost one out of every three US children is overweight or obese, with minority youth at highest risk. There are limited efficacious pediatric obesity interventions available for clinicians, and successful weight loss trials for minority youth are rare. Even fewer interventions have been shown to significantly improve clinical health outcomes such as adiposity, blood pressure, and cholesterol level, and maintenance of behavior change over the long-term remains a challenge Translation I research in which "bench" findings are applied to the "bedside" is uncommon in the behavioral arena. Thus, advances in our understanding of fundamental human processes such as motivation, emotion, cognition, self-regulation, decision-making, stress, and social networks are not being optimally applied to our most pressing behavioral health problems. This issue of Pediatric Clinics will focus on promising behavioral treatments "in the pipeline" that have been translated from basic behavioral science and are the process of refinement and proof of concept testing.

Originally published in French, this updated and expanded English translation offers a definitive treatment on clays and effects on human health including the long history of clays used as pharmaceutical and therapeutic agents, the origins of clays, their structural properties and modes of action.